Developing CD19 CAR-T for Autoimmune Disease & Early Clinical Insights

Time: 9:20 am
day: Conference Day Two


  • Leveraging pre-existing experience with CAR-T in oncology and HSCT in autoimmune disease for CAR-T in autoimmune disease
  • Designing the optimal CD19 CAR-T for autoimmune disease
  • Discussing early clinical insights from SLE patients treated with CD19 CAR-T cells